# Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis

> **NCT04855110** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 114 (estimated)

## Conditions studied

- Maternal Complications After Oral Anticoagulation When Initiated Early and Late After Caesarean Section Done for Patients With Mechanical Heart Valve Prosthesis

## Interventions

- **DRUG:** Warfarin Sodium started on Day 2 after caesarean section (in a dose that achieves a therapeutic level as indicated by the cardiology consultant)
- **DRUG:** Warfarin Sodium started on day 5 after caesarean section (in a dose that achieves a therapeutic level as indicated by the cardiology consultant)

## Key facts

- **NCT ID:** NCT04855110
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-19
- **Primary completion:** 2022-03
- **Final completion:** 2022-03
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2021-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04855110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04855110, "Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04855110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*